價格 | ¥378 | ¥549 | ¥892 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:化合物 R-268712 | 英文名稱:R-268712 |
CAS:879487-87-3 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.77% | 產(chǎn)品類別: 抑制劑 |
貨號: T16708 |
Name | R-268712 |
Description | R-268712 is a specific activin receptor-like kinase 5 (ALK5) inhibitor(IC50 of 2.5 nM). It is also an orally active transforming growth factor-β type I receptor inhibitor. |
In vitro | R-268712是一種新型且特異性的活化素受體樣激酶5(ALK5)抑制劑,ALK5是轉(zhuǎn)化生長因子β(TGF-β)類型I受體。體外抑制評估顯示,R-268712對ALK5具有強效和選擇性抑制作用,IC50為2.5nM,對ALK5的選擇性約為p38絲裂原活化蛋白激酶(MAPK)的5000倍。 |
In vivo | 通過口服給藥,R-268712以1、3及10mg/kg的劑量,在單側(cè)輸尿管阻塞(UUO)模型中,以劑量依賴性方式抑制了腎臟纖維化的發(fā)展。此外,R-268712在劑量為0.3及1mg/kg的半腎切除抗-Thy1腎小球腎炎模型中展現(xiàn)出療效。R-268712顯著降低了蛋白尿和腎小球硬化,并改善了腎功能。 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 110 mg/mL (302.7 mM), Sonication is recommended. |
Keywords | renal fibrosis | Thy1 nephritis | Transforming growth factor beta receptors | glomerulonephritis | Transforming growth factor beta | ALK tyrosine kinase receptor | HFL-1 | glomerulosclerosis | CD246 | Inhibitor | Cluster of differentiation 246 | R 268712 | UUO | Anaplastic lymphoma kinase (ALK) | R-268712 | inhibit | TGF-β | R268712 | TGF-beta/Smad | CKD | TGF-β Receptor | Anaplastic lymphoma kinase |
Inhibitors Related | Monocrotaline | Pirfenidone | Crizotinib | RepSox | Ceritinib | A 83-01 | Chromenone 1 | LY-364947 | BMP signaling agonist sb4 | SB-431542 | Galunisertib | Alantolactone |
Related Compound Libraries | Inhibitor Library | Immuno-Oncology Compound Library | Bioactive Compound Library | Bioactive Compounds Library Max | Kinase Inhibitor Library | Anti-Fibrosis Compound Library | Anti-Ovarian Cancer Compound Library | TGF-beta/Smad Compound Library | Membrane Protein-targeted Compound Library | Tyrosine Kinase Inhibitor Library |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學,分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP11年
|
四川省維克奇生物科技有限公司
|
2024-11-19 | |
詢價 |
VIP5年
|
上海澤葉生物科技有限公司
|
2024-11-19 | |
詢價 |
ALL Chemistry Inc.
|
2023-02-24 |